Previous Article | Next Article 
Applied and Environmental Microbiology, April 2001, p. 1418-1422, Vol. 67, No. 4
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.4.1418-1422.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Biological Activities and Structural Properties of
the Atypical Bacteriocins Mesenterocin 52B and Leucocin
B-TA33a
C.
Corbier,1
F.
Krier,2
G.
Mulliert,1
B.
Vitoux,1 and
A.-M.
Revol-Junelles2,*
Laboratoire de Cristallographie et
Modélisation des Matériaux Minéraux et Biologiques,
Groupe Biocristallographie, UPRESA CNRS 7036, Université Henri
Poincaré-Nancy I, 54506 Vandoeuvre-lès-Nancy
cedex,1 and Laboratoire de
Bioprocédés Agro-Alimentaires, Ecole Nationale
Supérieure d'Agronomie et des Industries Alimentaires
Institut
National Polytechnique de Lorraine (ENSAIA-INPL), 54505 Vandoeuvre-lès-Nancy cedex,2 France
Received 27 July 2000/Accepted 17 January 2001
 |
ABSTRACT |
The antibacterial spectra and modes of action of
synthetic peptides corresponding to mesenterocin 52B and leucocin
B-TA33a greatly differ despite their high sequence homology. Circular dichroism experiments establish the capacity of each of these two
peptides to partly fold into an amphiphilic helix that might be crucial
for their adsorption at lipophilic-hydrophilic interfaces.
 |
INTRODUCTION |
Among the various antimicrobial
compounds produced by lactic acid bacteria, bacteriocins are bioactive
single polypeptides or polypeptide complexes that are active against
closely related bacterial species (14, 15, 22). These
bacteriocins constitute a large family of metabolites, which can be
subdivided into different classes based on their modes of action and
their structures (14). In particular, class II
bacteriocins are small, heat-stable, non-lanthionine-containing peptides, varying between 30 and 60 residues in length (<10 kDa) (8). Subgroups have been defined within class II, notably
the class IIa bacteriocins, which contain a consensus YGNGV amino acid
motif near the N terminus and are active against Listeria spp. Within the class IIa bacteriocins produced by some
Leuconostoc strains (11, 12, 18, 20), the
closely related leucocin A and mesentericin Y105 have been the subject
of numerous studies, including conformational ones (9,
10). In low-polarity medium, mesentericin Y105 was found to be
partially folded as an amphipathic helix spanning over residues 17 to
31 (9), and leucocin A is proposed to adopt an amphiphilic
-helical conformation in its C-terminal region, whereas the
N-terminal part would fold into a three-stranded anti-parallel
-sheet conformation (10).
Within the Leuconostoc genus, some strains have been
recently shown to produce more than one bacteriocin. In addition to
mesenterocin 52A, which is identical to mesentericin Y105,
Leuconostoc mesenteroides subsp. mesenteroides
FR52 produces the 32-mer polypeptide mesenterocin 52B
(20). The same bacteriocin has also been detected in
culture extracts of L. mesenteroides Y105 (1).
L. mesenteroides strain TA33a actually produces three
different bacteriocins: class IIa leucocin A-TA33a, leucocin B-TA33a,
and leucocin C-TA33a, a new anti-Listeria bacteriocin
(18, 19). It is noteworthy that mesenterocin 52B and
leucocin B-TA33a display narrow spectra of activity limited to the
genera Leuconostoc and Weissella (18, 19,
20). Thus, they can be distinguished from other metabolites produced by Leuconostoc sp. strains (11, 12, 19,
20). The primary structures of the two bacteriocins are
presented in Table 1. By shifting the
mesenterocin 52B sequence forward by two positions, identical amino
acids appear in 17 positions and lead to a 63% identity score between
the two peptides. The similarity is most obvious in the central
domain of the peptide, where the LTGPQQP motif is present in
the two bacteriocins. As both mesenterocin 52B and leucocin
B-TA33a are small heat-stable and non-lanthionine-containing peptides,
their classification as bacteriocins from class II is obvious.
Yet, in addition to the uncommon biological properties cited above, the
sequences of both mesenterocin 52B and leucocin B-TA33a contain neither
the YGNGV consensus motif shared by all other Leuconostoc
bacteriocins nor the conserved disulfide bridge which is considered a
characteristic feature of the IIa subgroup (8).
In this study, synthetic peptides representative of bacteriocins
mesenterocin 52B and leucocin B-TA33a were characterized and compared
with respect to their biological activities and secondary-structure propensities. To study the latter characteristic, both peptides were
examined by circular dichroism (CD) under a variety of conditions including aqueous or micellar media.
 |
MATERIALS AND METHODS |
Synthesis of peptides.
Mesenterocin 52B and leucocin B-TA33a
were synthesized according to the amino acid sequences reported earlier
(19, 20). They were prepared by stepwise solidphase
peptide synthesis, as described by Fleury et al. (9).
Purity of the synthetic peptides was assessed by mass spectrum and
solid-phase sequence analyses (9).
Microbial strains and bacteriocin activity.
Strains used as
indicator microorganisms are listed in Table
2 and were grown statically at 30°C in
MRS broth (Biokar, Beauvais, France). The bacterial strains were
maintained frozen at
24°C and were propagated twice in broth medium
before use. Aqueous solutions of both bacteriocins were prepared by
solubilizing 1.2 mg of the synthetic peptides per ml in a 5 mM
phosphate buffer (pH 6.5). The solutions were then heated at 80°C
during 20 min to prevent cell contamination. Bacteriocin activities
were determined by the agar well diffusion method (20).
MICs were determined by a critical dilution assay. Stationary-phase
cells of Weissella paramesenteroides LMA 19 and
Leuconostoc pseudomesenteroides CIP 103316 obtained after
16 h at 30°C in MRS broth were used to inoculate (10%, vol/vol)
MRS broth. Bacteriocins were then added to a final concentration of
0.03 mg/ml. Samples were incubated at 30°C and aliquots were taken at
appropriate intervals of time to determine the number of viable cells
(in CFU per milliliter) by plate counts in MRS medium agar (12 g/liter)
after incubation at 30°C for 48 h.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Antimicrobial activitiesa of
synthetic mesenterocin 52B and leucocin B-TA33a (1.2 mg/ml) against 28 bacterial indicator strains in a 5 mM phosphate buffer (pH 6.5)
|
|
CD and amphipathic properties.
CD spectra were recorded by
using a Jobin-Yvon CD6 dichrograph calibrated with epiandrosterone.
Measurements were performed at 20°C using a 0.2-cm-path-length quartz
cell, a 2-nm bandwidth, a scan speed of 20 nm/min, a time constant of
2 s, and at least three scan accumulations. A protein-free control
spectrum was recorded for each condition and subtracted from the
protein spectra. Peptides were dissolved in 20 mM phosphate buffer, pH
7, and most measurements were done at a peptide concentration of 24 µM. The results are reported as mean residual ellipticity in degrees
per square centimeter per decimole. The contents in the
-helical structures of the peptides were calculated from the mean residual ellipticity at 222 nm (16). Hydrophobic moments were
calculated according to the method of Eisenberg et al.
(7), and the helical wheel representations were drawn as
implemented in GCG, version 8.0.
 |
RESULTS |
Biological activities of mesenterocin 52B and leucocin
B-TA33a.
The antibacterial spectra of activity of the two
bacteriocins were assayed against 32 indicator strains belonging to the
genera Leuconostoc and Weissella (Table 2), since
no activity was detected against other gram-positive genera (18,
20). Mesenterocin 52B inhibited many more strains than did
leucocin B-TA33a. At the bacteriocin concentration tested, some strains
appeared to be resistant to both peptides. For the indicator strains
sensitive to both bacteriocins, sensitivities to mesenterocin 52B and
leucocin B-TA33a appeared to vary considerably from one strain to
another, with over 100-fold differences between the two MICs for a
given strain as a function of the tested bacteriocin, as well as over 100-fold differences between the MICs of a given bacteriocin as a
function of the indicator strain used.
The modes of action of the two bacteriocins (0.03 mg/ml) were examined
during the growth of
W. paramesenteroides LMA 19 and
L. pseudomesenteroides CIP 103316 in MRS broth at 30°C.
Figure
1 shows bactericidal effects of
the two peptides against the two
sensitive strains, but there are
marked differences. In both cases,
leucocin B-TA33a displayed a more
rapid rate of bactericidal action
than mesenterocin 52B. With
mesenterocin 52B, the bactericidal
effect against
W. paramesenteroides LMA 19 occurred immediately
after bacteriocin
addition, while it was detected only after 2
h of contact in the
case of
L. pseudomesenteroides CIP 103316.
Furthermore,
bactericidal action of mesenterocin 52B vanished
after 8 h of
contact, and survivor cells resumed growth.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Kinetics of death of W. paramesenteroides LMA
19 cells (A) and L. pseudomesenteroides CIP 103316 cells (B)
in MRS broth at 30°C. , control; , mesenterocin 52B (0.03 mg/ml); , leucocin B-TA33a (0.03 mg/ml).
|
|
CD experiments and helical propensities.
In the pH range of 4 to 8, the CD spectra of both peptides in aqueous solution are typical
of an unordered conformation with an
-helical content below 2%. In
20 mM phosphate buffer, pH 7, the molar ellipticity does not depend on
the peptide concentration (2 to 200 µM) and is characteristic of a
random coil conformation. Within this concentration range and in
aqueous media, both peptides thereby remain essentially disordered and
monomeric. This is consistent with results provided by predictive
methods related to the helical behavior of monomeric peptides
(17), which lead to the conclusions that helix levels of
both bacteriocins would be less than 3% under these CD conditions.
As a solvent suitable for spectroscopic experiments, trifluoroethanol
(TFE) is known to induce and stabilize

-helical structures
in
peptides that possess an intrinsic tendency to adopt this kind
of
secondary structure. In the presence of TFE, both compounds
give
spectra typical of partly

-helical peptides, with a maximum

-helical content (39% for mesenterocin 52B and 43% for leucocin
B-TA33a) obtained for a TFE concentration of 50% (results not
shown).
A further increase of the TFE concentration up to 75%
does not result
in any increase of the

-helical
content.
In order to examine the peptide behavior in membrane-mimicking media,
CD spectra were then recorded in the presence of sodium
dodecyl sulfate
(SDS) at concentrations ranging from 1 µM to 20
mM. Surprisingly,
concentrations of SDS as low as 2 µM induced
a significant transition
towards

helix formation (15%

-helicoidal
content) for both
peptides and a maximum of 36 to 38% of

helix
content was obtained
for SDS concentrations greater than or equal
to 0.05 mM (Fig.
2). An isodichroic point is observed near
200
nm, indicating a local two-state (

-helical/random coil)
population
equilibrium (
13) even at a high SDS
concentration. Furthermore,
since

-helical appearance is obtained
for SDS concentrations
much lower than the 8 mM critical micellar
concentration (CMC),
this implies that peptide structuralization does
not depend upon
micelle formation and that smaller aggregates of SDS
are sufficient
to induce the transition. In order to investigate
whether the
negative charge of SDS was essential for this interaction,
similar
experiments were carried out in the presence of
tetradecyltrimethylammonium
bromide (TTAB), a cationic counterpart of
SDS with very similar
physicochemical properties. The spectra obtained
in TTAB (concentrations
ranging from 1 µM to 10 mM, with a CMC of 3.6 mM [
2]) are not
significantly different from those
obtained in aqueous solution
and typically account for a random coil
conformation (Fig.
3).
Thus, given the
nearly identical hydrophobic behaviors of the
aliphatic parts of both
SDS and TTAB, induction of

-helical formation
within peptides
appears to depend on the electrostatic properties
of the polar head of
the detergent used.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of SDS on the CD spectra of leucocin B-TA33a and
mesentorocin 52B in aqueous solution. The spectra of the two peptides
(24 µM in 20 mM phosphate buffer, pH 7) were recorded in the absence
or in the presence of various amounts of SDS. (A) Leucocin B-TA33a.
Concentrations of SDS were as follows: none ( ), 5 µM ( ), 10 µM ( ), 30 µM ( ), and 10 mM (+). (B) Mesenterocin 52B. SDS
concentrations were as follows: none ( ), 20 µM ( ), 50 µM
( ), 0.2 mM ( ), and 20 mM (+).
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of TTAB on the CD spectra of mesenterocin 52B in
aqueous solution (24 µM peptide, 10 mM phosphate, pH 7). The spectra
were recorded in the wavelength range of 180 to 250 nm except for the
highest concentrations of TTAB (205 to 252 nm) because of the strong
absorption of this compound at short wavelengths. TTAB concentrations
were as follows: none ( ), 1 mM ( ), 2 mM ( ), 4 mM ( ), and 10 mM (+).
|
|
Finally, CD spectra were recorded in the presence of
dodecyllysophosphatidylcholine (LPC) (concentration range of
55 µM to
10 mM, with a CMC value of 1.1 mM
[
21]).

-Helical structure
was induced in leucocin
B-TA33a and mesenterocin 52B only once
the LPC concentration exceeded
the CMC and maximal

-helical content
(42 and 40%, respectively) was
reached for 3.3 mM LPC (Fig.
4).
Similar
experiments carried out at different peptide concentrations
in order to
change the lipid/peptide ratio for the same LPC concentrations
led
essentially to the same conclusions: a micellar environment
is required
to induce peptide structuralization. The zwitterionic
nature of the LPC
polar head proceeds from the simultaneous presence
of a negatively
charged phosphodiester group and a positively
charged quaternary
ammonium group. If the negative charge of SDS
is essential to the
formation of bacteriocin secondary structures,
especially at
submicellar concentrations (see above), isolated
LPC molecules may be
unable to tightly interact with the peptides
because of the
contradictory effects resulting from their positive
and negative
neighboring charges. In contrast, a micellar environment
would allow a
local concentration of negative charges by appropriately
orienting the
LPC molecules close to the bacteriocin molecules
and thus would provide
a suitable environment for the initial
adhesion of both peptides to the
micellar interface.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
CD spectra of mesenterocin 52B in aqueous solution (24 µM peptide, 10 mM phosphate, pH 7) at the following LPC
concentrations: none ( ), 0.6 mM ( ), 1 mM ( ), 2mM ( ), and
3.3 mM (+).
|
|
In order to account for the amphipathic character likely associated
with the occurrence of peptide-surfactant attractive interactions,
we
looked for the hydrophobic moment profile along the sequences
of the
two bacteriocins folded into an

-helical structure. The
highest
magnitude of putative amphipathy was observed within a
fragment
ranging from 10 to 15 residues in length and centered
at positions 8 and 10 in the mesenterocin 52B and leucocin B-TA33a
sequences,
respectively. The

-helical wheel representation (Fig.
5) clearly illustrates the amphiphilic
character of this fragment
for the two bacteriocins.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Edmunsen -helical wheel representation of the
amphiphilic region of leucocin B-T33a (A) and mesenterocin 52B (B). The
amphiphilic region starts with residue 3 and ends with residue 17 in
the leucocin B-T33a sequence, whereas it starts with residue 1 and ends
with residue 15 for mesenterocin B52. The boxes denote hydrophobic
residues.
|
|
 |
DISCUSSION |
Some lactic acid bacterial strains produce more than one type of
bacteriocin (6, 18, 20). So, erroneous conclusions regarding the relationship between structure and activity of a single
bacteriocin could be drawn from activity measurements assessed only
with culture supernatant (6). A convenient way to avoid this problem is to use the synthetic counterparts of natural
bacteriocins (9), readily obtained by peptide synthesis
when posttranslational modifications do not occur. In the case of
synthetic mesenterocin 52B and leucocin B-TA33a, their activities were
previously shown to be similar to those obtained with equivalent
peptides isolated from natural sources (18, 20).
The antibacterial activity of each bacteriocin appears to be strongly
dependent on the indicator strain used. Furthermore, mesenterocin 52B
and leucocin B-TA33a display different antibacterial spectra and
activities despite their notable sequence homology. No global rule can,
then, be deduced from the comparative analysis of the two sets of
inhibitory data. The sequence alignment of the two peptides (Table 1)
reveals a homogeneous rate of homology along the whole sequences and
does not enable one to simply relate their activity profile to specific
fingerprints at the primary structure level.
Structure and activity investigations were then conducted by CD
experiments in order to determine whether or not mesenterocin 52B
and leucocin B-TA33a adopt the same conformation in different aqueous
lipophilic micellar systems. The structural studies presented here
clearly establish that both bacteriocins are able to adopt a
partially helical structure at amphiphilic interfaces, provided that
the required conditions (hydrophobic environment together with the
presence of negative charges) are fulfilled. Therefore, despite the
great differences in activity discussed above, the two peptides exhibit
exactly the same behavior from a structural point of view, and
predictions regarding the positions of helical elements along their
sequences (Fig. 5) obviously support the hypothesis of identical
three-dimensional properties. This similarity in the behaviors of the
two peptides when placed in a membrane-mimicking environment correlates
with the observation that the two bacteriocins are able to
spontaneously adsorb on the same strains, even if these strains are not
sensitive to one or both of the compounds (results not shown). This
probably occurs in a first general step of interaction between a
bacteriocin molecule and the target cell, during which a contact could
be established between the peptide and the bacterium, but which would
not preclude an efficient bactericidal effect. Apart from the likely
promoting role played by negatively charged phospholipid heads
(4) that was confirmed in the present study by the
comparison between the results obtained in the presence of SDS and
TTAB, the initial adsorption of a bacteriocin thus appears to depend
only on its capacity to adopt an amphipathic conformation in an
interfacial environment. After the achievement of an efficient
adsorption process, it is still not clear in which step different
behaviors between a sensitive and a nonsensitive strain take place. In
that context, the putative requirement for a specific receptor of
proteinaceous nature remains an open question at present (3,
5), especially if one considers the bacteriocin oligomerization
step that would undoubtedly be required for the pore formation process.
As underlined in the introduction, numerous studies have been carried
out on class IIa bacteriocins with the aim of identifying the regions
involved in cell recognition and bactericidal action. Altogether, these
studies have established that the pore formation process occurs through
several recognition steps involving different structural features of
the bacteriocins (for a complete review, see reference 8).
However, it is not possible to take advantage of these former studies
to find clues concerning the mechanisms of mesenterocin 52B and
leucocin B-TA33a. Indeed, it appears that these two bacteriocins are
rather atypical and differ clearly in sequence and in activity spectra
from class IIa bacteriocins as well as from bacteriocins of any other
subgroup. This raises the issue of the reliability of the
classification scheme used for bacteriocins, which has already been
addressed by Jack et al. (14) and Ennahar et al.
(8) with class IIa. In order to rationally refine the
criteria used for classification, a deeper knowledge of the mechanism
of action is required. In particular it would be of considerable
interest to make further enquiries in the field of the membrane
properties which certainly differentiate one bacterial species from
another, or even one strain from another, regarding their sensitivities
to bacteriocins.
 |
ACKNOWLEDGMENTS |
We thank A. Delfour and P. Nicolas (Institut Jacques Monod,
Université Paris VII, Paris, France) for providing the synthetic peptides. CD experiments were carried out in the Service Commun de
Biophysicochimie des interactions moléculaires of the
Université Henri Poincaré, Nancy I, France.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Bioprocédés Agro-Alimentaires, Ecole Nationale
Supérieure d'Agronomie et des Industries Alimentaires
Institut
National Polytechnique de Lorraine (ENSAIA-INPL), 2, Avenue de la
Forêt de Haye, 54505 Vandoeuvre-lès-Nancy cedex, France.
Phone: 00 33 3 83 59 58 84. Fax: 00 33 3 83 59 58 04. E-mail:
Anne-Marie.Revol{at}ensaia.inpl-nancy.fr.
 |
REFERENCES |
| 1.
|
Biet, F.,
J. M. Berjeaud,
R. W. Worobo,
Y. Cenatiempo, and C. Frémaux.
1998.
Heterologous expression of the bacteriocin mesentericin Y105 using the dedicated transport system and the general secretion pathway.
Microbiology
144:2845-2854[Abstract/Free Full Text].
|
| 2.
|
Castedo, A.,
J. L. Del Castillo,
M. J. Suarez-Filloy, and J. R. Rodriguez.
1997.
Effect of temperature on the mixed micellar tetradecyltrimethylammonium bromide-butanol system.
J. Colloid Interface Sci.
196:148-156[CrossRef][Medline].
|
| 3.
|
Chen, Y.,
R. Shapira,
M. Eisenstein, and T. J. Montville.
1997.
Functional characterization of pediocin PA-1 binding to liposomes in the absence of a protein receptor and its relationship to a predicted tertiary structure.
Appl. Environ. Microbiol.
63:524-531[Abstract].
|
| 4.
|
Chen, Y.,
R. D. Ludescher, and T. J. Montville.
1998.
Influence of lipid composition on pediocin PA-1 binding to phospholipid vesicles.
Appl. Environ. Microbiol.
64:3530-3532[Abstract/Free Full Text].
|
| 5.
|
Chikindas, M. L.,
M. J. Garcia-Garcera,
A. J. M. Driessen,
A. M. Ledeboer,
J. Nissen-Meyer,
I. F. Nes,
T. Abee,
W. N. Konings, and G. Venema.
1993.
Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells.
Appl. Environ. Microbiol.
59:3577-3584[Abstract/Free Full Text].
|
| 6.
|
Eijsink, V. G. H.,
M. Skeie,
P. H. Middelhoven,
M. B. Brurberg, and I. Nes.
1998.
Comparative studies of class IIa bacteriocins of lactic acid bacteria.
Appl. Environ. Microbiol.
64:3275-3281[Abstract/Free Full Text].
|
| 7.
|
Eisenberg, D.,
R. M. Weiss, and T. C. Terwilliger.
1982.
The helical hydrophobic moment: a measure of the amphiphilicity of a helix.
Nature
299:371-374[CrossRef][Medline].
|
| 8.
|
Ennahar, S.,
T. Sashihara,
K. Sonomoto, and A. Ishizaki.
2000.
Class IIa bacteriocins: biosynthesis, structure and activity.
FEMS Microbiol. Rev.
24:85-106[CrossRef][Medline].
|
| 9.
|
Fleury, Y.,
M. Abdel Dayem,
J. J. Montagnes,
E. Chaboisseau,
J. P. Le Caer,
P. Nicolas, and A. Delfour.
1995.
Covalent structure, synthesis, and structure-function studies of mesentericin Y10537, a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides.
J. Biol. Chem.
271:14421-14429[Abstract/Free Full Text].
|
| 10.
|
Fregeau-Gallagher, N. L.,
M. Sailer,
W. P. Niemczura,
T. T. Nakashima,
M. E. Stiles, and J. C. Vederas.
1997.
Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid bacteria.
Biochemistry
36:15062-15072[CrossRef][Medline].
|
| 11.
|
Hastings, J. W.,
M. Sailer,
K. Johnson,
K. L. Roy,
J. C. Vederas, and M. E. Stiles.
1991.
Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum.
J. Bacteriol.
173:7491-7500[Abstract/Free Full Text].
|
| 12.
|
Hechard, Y.,
B. Derijard,
F. Letellier, and Y. Cenatiempo.
1992.
Characterization and purification of mesentericin Y105, an anti-Listeria bacteriocin from Leuconostoc mesenteroides.
J. Gen. Microbiol.
138:2725-2731[Medline].
|
| 13.
|
Holtzer, M. E., and A. Holtzer.
1992.
Alpha-helix to random coil transitions: determination of peptide concentration from the isodichroic point.
Biopolymers
12:1675-1677.
|
| 14.
|
Jack, R. W.,
J. R. Tagg, and B. Ray.
1995.
Bacteriocins of gram-positive bacteria.
Microbiol. Rev.
59:171-200[Abstract/Free Full Text].
|
| 15.
|
Klaenhammer, T. R.
1993.
Genetics of bacteriocins produced by lactic acid bacteria.
FEMS Microbiol. Rev.
12:39-86[Medline].
|
| 16.
|
Kortemme, T., and T. E. Creighton.
1995.
Ionisation of cysteine residues at the termini of model alpha-helical peptides. Relevance to unusual thiol pKa values in proteins of the thioredoxin family.
J. Mol. Biol.
253:799-812[CrossRef][Medline].
|
| 17.
|
Munoz, V., and L. Serrano.
1997.
Development of the multiple sequence approximation within the AGADIR model of -helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms.
Biopolymers
41:495-509[CrossRef][Medline].
|
| 18.
|
Papathanasopoulos, M. A.,
F. Krier,
A.-M. Revol-Junelles,
G. Lefebvre,
J. P. Le Caer,
A. von Holy, and J. W. Hastings.
1997.
Multiple bacteriocin production by Leuconostoc mesenteroides TA33a and other Leuconostoc/Weissella strains.
Curr. Microbiol.
35:331-335[CrossRef][Medline].
|
| 19.
|
Papathanasopoulos, M. A.,
G. A. Dykes,
A.-M. Revol-Junelles,
A. Delfour,
A. von Holy, and J. W. Hastings.
1998.
Sequence and structural relationships of leucocins A-, B- and C-TA33a from Leuconostoc mesenteroides TA33a.
Microbiology
144:1343-1348[Abstract/Free Full Text].
|
| 20.
|
Revol-Junelles, A.-M.,
R. Mathis,
F. Krier,
A. Delfour, and G. Lefebvre.
1996.
Leuconostoc mesenteroides subsp. mesenteroides FR52 synthetize two distinct bacteriocins.
Lett. Appl. Microbiol.
23:120-124[Medline].
|
| 21.
|
Stafford, R. E.,
T. Fanni, and E. A. Dennis.
1989.
Interfacial properties and critical micelle concentration of lysophospholipids.
Biochemistry
13:5113-5120.
|
| 22.
|
Tagg, J. R.,
A. S. Dajani, and L. W. Wannamaker.
1976.
Bacteriocins of gram-positive bacteria.
Bacteriol. Rev.
40:722-756[Free Full Text].
|
Applied and Environmental Microbiology, April 2001, p. 1418-1422, Vol. 67, No. 4
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.4.1418-1422.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Morisset, D., Berjeaud, J.-M., Marion, D., Lacombe, C., Frere, J.
(2004). Mutational Analysis of Mesentericin Y105, an Anti-Listeria Bacteriocin, for Determination of Impact on Bactericidal Activity, In Vitro Secondary Structure, and Membrane Interaction. Appl. Environ. Microbiol.
70: 4672-4680
[Abstract]
[Full Text]
-
Limonet, M., Revol-Junelles, A.-M., Milliere, J.-B.
(2002). Variations in the Membrane Fatty Acid Composition of Resistant or Susceptible Leuconostoc or Weissella Strains in the Presence or Absence of Mesenterocin 52A and Mesenterocin 52B Produced by Leuconostoc mesenteroides subsp. mesenteroides FR52. Appl. Environ. Microbiol.
68: 2910-2916
[Abstract]
[Full Text]